This episode explores the dynamic landscape of Cardiac Implantable Electronic Devices (CIEDs), including pacemakers, ICDs, and CRT devices. We discuss why these devices are now a routine therapy, driven by an aging population and technological advancements. We cover key innovations like leadless technology, remote monitoring, and MRI-conditional labeling, and examine market trends for 2024-2025, including conduction-system pacing, highlighting how these devices remain a cornerstone of modern cardiology. Key Questions: - What factors are driving the widespread adoption of CIEDs? - How many new CIEDs are implanted annually in the U.S. alone? - What are the most significant recent innovations in pacemaker and ICD technology? - How does cloud-based remote monitoring improve patient outcomes and clinic efficiency? - What does the large existing patient base mean for the future of the CIED market? - What key trends for 2024–2025 are shaping the next generation of cardiac implants? - Why are these devices considered a mainstay for treating arrhythmias and heart failure? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, helping you navigate the complex global market for devices like CIEDs. We develop efficient regulatory strategies and use advanced AI to compile technical dossiers for submission, streamlining your path to market access. Whether you're a startup or a multinational enterprise, our local experts across 30+ markets can act as your representative and ensure continuous compliance. To accelerate your global expansion and access free AI tools and regulatory databases, visit us at https://pureglobal.ai or contact [email protected].